Contact this trialFirst, we need to learn more about you.
NMDA Receptor Antagonist
Ketamine for Suicidal Thoughts
Recruiting1 awardPhase 1
Kansas City, Kansas
This trial will test if ketamine can be used to reduce suicidal thoughts in those who present to an Emergency Dept.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.